167 related articles for article (PubMed ID: 29769411)
1. Knockdown of Rab7a suppresses the proliferation, migration, and xenograft tumor growth of breast cancer cells.
Xie J; Yan Y; Liu F; Kang H; Xu F; Xiao W; Wang H; Wang Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 29769411
[TBL] [Abstract][Full Text] [Related]
2. ERCC6L, a DNA helicase, is involved in cell proliferation and associated with survival and progress in breast and kidney cancers.
Pu SY; Yu Q; Wu H; Jiang JJ; Chen XQ; He YH; Kong QP
Oncotarget; 2017 Jun; 8(26):42116-42124. PubMed ID: 28178669
[TBL] [Abstract][Full Text] [Related]
3. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
4. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of CARD14 Inhibits Cell Proliferation and Migration in Breast Cancer Cells.
Lim JY; Kim SW; Kim B; Park SJ
Anticancer Res; 2020 Apr; 40(4):1953-1962. PubMed ID: 32234884
[TBL] [Abstract][Full Text] [Related]
7. Role of synaptotagmin 13 (SYT13) in promoting breast cancer and signaling pathways.
Zhang YD; Zhong R; Liu JQ; Sun ZX; Wang T; Liu JT
Clin Transl Oncol; 2023 Jun; 25(6):1629-1640. PubMed ID: 36630025
[TBL] [Abstract][Full Text] [Related]
8. Deletion of sorting nexin 27 suppresses proliferation in highly aggressive breast cancer MDA-MB-231 cells in vitro and in vivo.
Zhang J; Li K; Zhang Y; Lu R; Wu S; Tang J; Xia Y; Sun J
BMC Cancer; 2019 Jun; 19(1):555. PubMed ID: 31182056
[TBL] [Abstract][Full Text] [Related]
9. SIN1 promotes the proliferation and migration of breast cancer cells by Akt activation.
Wang D; Wu P; Wang H; Zhu L; Zhao W; Lu Y
Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 27780891
[TBL] [Abstract][Full Text] [Related]
10. Silencing ARHGAP9 correlates with the risk of breast cancer and inhibits the proliferation, migration, and invasion of breast cancer.
Wang T; Ha M
J Cell Biochem; 2018 Sep; 119(9):7747-7756. PubMed ID: 29905031
[TBL] [Abstract][Full Text] [Related]
11. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25.
Yin C; Mou Q; Pan X; Zhang G; Li H; Sun Y
Thorac Cancer; 2018 Apr; 9(4):472-479. PubMed ID: 29524309
[TBL] [Abstract][Full Text] [Related]
12. Effect of SALL4 on the Proliferation, Invasion and Apoptosis of Breast Cancer Cells.
Liu C; Yao F; Mao X; Li W; Chen H
Technol Cancer Res Treat; 2020; 19():1533033820980074. PubMed ID: 33308020
[TBL] [Abstract][Full Text] [Related]
13. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
Han W; Cao F; Gao XJ; Wang HB; Chen F; Cai SJ; Zhang C; Hu YW; Ma J; Gu X; Ding HZ
Int J Oncol; 2018 Sep; 53(3):937-948. PubMed ID: 29956756
[TBL] [Abstract][Full Text] [Related]
14. Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.
Yuan SS; Hou MF; Hsieh YC; Huang CY; Lee YC; Chen YJ; Lo S
J Natl Cancer Inst; 2012 Oct; 104(19):1485-502. PubMed ID: 22914783
[TBL] [Abstract][Full Text] [Related]
15. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
16. Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism.
Meng D; Yu Q; Feng L; Luo M; Shao S; Huang S; Wang G; Jing X; Tong Z; Zhao X; Liu R
Clin Transl Oncol; 2019 Jul; 21(7):910-923. PubMed ID: 30565087
[TBL] [Abstract][Full Text] [Related]
17. Effects of the knockdown of death-associated protein 3 expression on cell adhesion, growth and migration in breast cancer cells.
Wazir U; Sanders AJ; Wazir AM; Ye L; Jiang WG; Ster IC; Sharma AK; Mokbel K
Oncol Rep; 2015 May; 33(5):2575-82. PubMed ID: 25738636
[TBL] [Abstract][Full Text] [Related]
18. SIRT7 depletion inhibits cell proliferation, migration, and increases drug sensitivity by activating p38MAPK in breast cancer cells.
Chen KL; Li L; Yang FX; Li CM; Wang YR; Wang GL
J Cell Physiol; 2018 Sep; 233(9):6767-6778. PubMed ID: 29231244
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of PEBP4 suppresses proliferation, migration and invasion of human breast cancer cells.
Wang SC; Zhou F; Zhou ZY; Hu Z; Chang L; Ma MD
Biomed Pharmacother; 2017 Jun; 90():659-664. PubMed ID: 28415045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]